BENGALURU (Reuters) - India's government said on Tuesday it has approved Gilead Sciences Inc's antiviral drug remdesivir for emergency use in treating COVID-19 patients. Remdesivir is the first drug to show improvement...
Full ArticleIndia approves emergency use of remdesivir to treat COVID-19 patients
WorldNews
0 shares
1 views
You might like
Related news coverage
11 critical questions about the coronavirus that remain unanswered, 6 months after the first cases were reported
Business Insider
· Experts continue to study the coronavirus as the number of people it infects and kills rises each day.
· Scientists are..
Advertisement
More coverage
Gilead Announces Clinical Trial For An Inhaled Version Of Remdesivir
Newsy
Watch VideoGilead Sciences announced Monday it will start human clinical trials for an inhaled version of remdesivir as a potential..
-
Coronavirus outbreak: Mumbai, parts of Maharashtra to get COVID-19 drug soon
Mid-Day
-
Gilead to start trial of inhaled version of Covid-fighting remdesivir
bizjournals
-
Gilead to start testing inhaled version of experimental coronavirus drug remdesivir, CEO says
FOXNews.com
-
Coronavirus: What’s happening in the labs of pharma companies worldwide
Proactive Investors